Global Interleukin 17A Market Professional Survey Report 2019

Table of Contents

Executive Summary

1 Industry Overview of Interleukin 17A

• 1.1 Definition of Interleukin 17A
• 1.2 Interleukin 17A Segment by Type
  • 1.2.1 Global Interleukin 17A Production Growth Rate Comparison by Types (2014-2025)
  • 1.2.2 ABY-035
  • 1.2.3 CNTO-6785
  • 1.2.4 DLX-2882
  • 1.2.5 Others
• 1.3 Interleukin 17A Segment by Applications
  • 1.3.1 Global Interleukin 17A Consumption Comparison by Applications (2014-2025)
  • 1.3.2 Chronic Pain
  • 1.3.3 Liver Cancer
  • 1.3.4 Kidney Cancer
  • 1.3.5 Others
• 1.4 Global Interleukin 17A Overall Market
  • 1.4.1 Global Interleukin 17A Revenue (2014-2025)
  • 1.4.2 Global Interleukin 17A Production (2014-2025)
  • 1.4.3 North America Interleukin 17A Status and Prospect (2014-2025)
  • 1.4.4 Europe Interleukin 17A Status and Prospect (2014-2025)
  • 1.4.5 China Interleukin 17A Status and Prospect (2014-2025)
  • 1.4.6 Japan Interleukin 17A Status and Prospect (2014-2025)
  • 1.4.7 Southeast Asia Interleukin 17A Status and Prospect (2014-2025)
  • 1.4.8 India Interleukin 17A Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis

• 2.1 Raw Material and Suppliers
• 2.2 Manufacturing Cost Structure Analysis of Interleukin 17A
• 2.3 Manufacturing Process Analysis of Interleukin 17A
• 2.4 Industry Chain Structure of Interleukin 17A

3 Development and Manufacturing Plants Analysis of Interleukin 17A

• 3.1 Capacity and Commercial Production Date
• 3.2 Global Interleukin 17A Manufacturing Plants Distribution
• 3.3 Major Manufacturers Technology Source and Market Position of Interleukin 17A
• 3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers

• 4.1 Interleukin 17A Production and Capacity Analysis
• 4.2 Interleukin 17A Revenue Analysis
• 4.3 Interleukin 17A Price Analysis
• 4.4 Market Concentration Degree

5 Interleukin 17A Regional Market Analysis

• 5.1 Interleukin 17A Production by Regions
  • 5.1.1 Global Interleukin 17A Production by Regions
  • 5.1.2 Global Interleukin 17A Revenue by Regions
• 5.2 Interleukin 17A Consumption by Regions
• 5.3 North America Interleukin 17A Market Analysis
  • 5.3.1 North America Interleukin 17A Production
  • 5.3.2 North America Interleukin 17A Revenue
  • 5.3.3 Key Manufacturers in North America
  • 5.3.4 North America Interleukin 17A Import and Export
• 5.4 Europe Interleukin 17A Market Analysis
  • 5.4.1 Europe Interleukin 17A Production
  • 5.4.2 Europe Interleukin 17A Revenue
  • 5.4.3 Key Manufacturers in Europe
  • 5.4.4 Europe Interleukin 17A Import and Export
• 5.5 China Interleukin 17A Market Analysis
  • 5.5.1 China Interleukin 17A Production
  • 5.5.2 China Interleukin 17A Revenue
  • 5.5.3 Key Manufacturers in China
  • 5.5.4 China Interleukin 17A Import and Export
• 5.6 Japan Interleukin 17A Market Analysis
  • 5.6.1 Japan Interleukin 17A Production
  • 5.6.2 Japan Interleukin 17A Revenue
  • 5.6.3 Key Manufacturers in Japan
  • 5.6.4 Japan Interleukin 17A Import and Export
• 5.7 Southeast Asia Interleukin 17A Market Analysis
  • 5.7.1 Southeast Asia Interleukin 17A Production
  • 5.7.2 Southeast Asia Interleukin 17A Revenue
  • 5.7.3 Key Manufacturers in Southeast Asia
  • 5.7.4 Southeast Asia Interleukin 17A Import and Export
• 5.8 India Interleukin 17A Market Analysis
  • 5.8.1 India Interleukin 17A Production
  • 5.8.2 India Interleukin 17A Revenue
  • 5.8.3 Key Manufacturers in India
  • 5.8.4 India Interleukin 17A Import and Export

6 Interleukin 17A Segment Market Analysis (by Type)

• 6.1 Global Interleukin 17A Production by Type
• 6.2 Global Interleukin 17A Revenue by Type
• 6.3 Interleukin 17A Price by Type

7 Interleukin 17A Segment Market Analysis (by Application)

• 7.1 Global Interleukin 17A Consumption by Application
• 7.2 Global Interleukin 17A Consumption Market Share by Application (2014-2019)

8 Interleukin 17A Major Manufacturers Analysis

• 8.1 AbbVie Inc
  • 8.1.1 AbbVie Inc Interleukin 17A Production Sites and Area Served
  • 8.1.2 AbbVie Inc Product Introduction, Application and Specification
  • 8.1.3 AbbVie Inc Interleukin 17A Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.1.4 Main Business and Markets Served
• 8.2 Abeome Corporation
  • 8.2.1 Abeome Corporation Interleukin 17A Production Sites and Area Served
  • 8.2.2 Abeome Corporation Product Introduction, Application and Specification
  • 8.2.3 Abeome Corporation Interleukin 17A Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.2.4 Main Business and Markets Served
• 8.3 Affibody AB
  • 8.3.1 Affibody AB Interleukin 17A Production Sites and Area Served
  • 8.3.2 Affibody AB Product Introduction, Application and Specification
  • 8.3.3 Affibody AB Interleukin 17A Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.3.4 Main Business and Markets Served
• 8.4 Cell Medica Limited
  • 8.4.1 Cell Medica Limited Interleukin 17A Production Sites and Area Served
  • 8.4.2 Cell Medica Limited Product Introduction, Application and Specification
  • 8.4.3 Cell Medica Limited Interleukin 17A Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.4.4 Main Business and Markets Served
• 8.5 Eli Lilly and Company
  • 8.5.1 Eli Lilly and Company Interleukin 17A Production Sites and Area Served
  • 8.5.2 Eli Lilly and Company Product Introduction, Application and Specification
  • 8.5.3 Eli Lilly and Company Interleukin 17A Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.5.4 Main Business and Markets Served
• 8.6 Johnson & Johnson
  • 8.6.1 Johnson & Johnson Interleukin 17A Production Sites and Area Served
  • 8.6.2 Johnson & Johnson Product Introduction, Application and Specification
  • 8.6.3 Johnson & Johnson Interleukin 17A Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.6.4 Main Business and Markets Served
• 8.7 Merck KGaA
  • 8.7.1 Merck KGaA Interleukin 17A Production Sites and Area Served
  • 8.7.2 Merck KGaA Product Introduction, Application and Specification
  • 8.7.3 Merck KGaA Interleukin 17A Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.7.4 Main Business and Markets Served
• 8.8 Novartis AG
  • 8.8.1 Novartis AG Interleukin 17A Production Sites and Area Served
  • 8.8.2 Novartis AG Product Introduction, Application and Specification
  • 8.8.3 Novartis AG Interleukin 17A Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.8.4 Main Business and Markets Served
• 8.9 Orega Biotech SAS
  • 8.9.1 Orega Biotech SAS Interleukin 17A Production Sites and Area Served
  • 8.9.2 Orega Biotech SAS Product Introduction, Application and Specification
  • 8.9.3 Orega Biotech SAS Interleukin 17A Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.9.4 Main Business and Markets Served

9 Development Trend of Analysis of Interleukin 17A Market

• 9.1 Global Interleukin 17A Market Trend Analysis
  • 9.1.1 Global Interleukin 17A Market Size (Volume and Value) Forecast 2019-2025
• 9.2 Interleukin 17A Regional Market Trend
  • 9.2.1 North America Interleukin 17A Forecast 2019-2025
  • 9.2.2 Europe Interleukin 17A Forecast 2019-2025
  • 9.2.3 China Interleukin 17A Forecast 2019-2025
  • 9.2.4 Japan Interleukin 17A Forecast 2019-2025
  • 9.2.5 Southeast Asia Interleukin 17A Forecast 2019-2025
  • 9.2.6 India Interleukin 17A Forecast 2019-2025
• 9.3 Interleukin 17A Market Trend (Product Type)
• 9.4 Interleukin 17A Market Trend (Application)
• 10.1 Marketing Channel
  • 10.1.1 Direct Marketing
  • 10.1.2 Indirect Marketing
• 10.3 Interleukin 17A Customers

11 Market Dynamics

• 11.1 Market Trends
• 11.2 Opportunities
• 11.3 Market Drivers
• 11.4 Challenges
• 11.5 Influence Factors

12 Conclusion

13 Appendix

• 13.1 Methodology/Research Approach
  • 13.1.1 Research Programs/Design
  • 13.1.2 Market Size Estimation
  • 13.1.3 Market Breakdown and Data Triangulation
• 13.2 Data Source
  • 13.2.1 Secondary Sources
  • 13.2.2 Primary Sources
• 13.3 Author List